2028年までの欧州免疫組織化学市場予測 - アプリケーション（診断および薬物検査）、製品（抗体、機器、試薬、キット）、およびエンドユーザー（病院および診断研究所、研究機関、その他）ごとの新型コロナウイルス感染症の影響と地域分析

市場紹介

ヨーロッパは免疫組織化学の第 2 位の市場であり、英国、ドイツ、フランス、イタリア、スペイン、その他の国々も同様です。ヨーロッパの国々がこの地域のこの市場に大きく貢献しています。ドイツは予測期間中に市場をリードしました。ドイツでは近年、がん症例が大幅に増加しています。たとえば、世界がん観測所によると、2020年には男女および全年齢で合計628,519人の新規症例が発見され、乳がんの症例は69,697人（11.1％）、乳がんの症例は67,959人（10.8％）でした。前立腺がん、64,804人（10.3％）、肺がん、57,528人（9.2％）、結腸直腸がん、35,147人（5.6％）、膀胱がん、および333,384人（53％）その他のがん。免疫組織化学はがんの診断と管理に広く使用されています。したがって、この国では免疫組織化学の需要が高まっています。この国では心血管疾患の有病率が増加しています。高齢者人口は心血管疾患の有病率の増加に主に寄与しています。人口動態の変化により、患者ケアに大きな課題が生じています。人口の高齢化に伴い、慢性疾患の数も着実に増加しています。同時に、医療分野におけるコスト圧力も高まっています。 Max Planck Institute 2019 が述べているように、この国では成人の約 30 ～ 40% が高血圧です。年齢が上がるにつれて発生率は増加し、60歳を超えるとCVDを発症する可能性が高くなります。 IHC は、がん、感染症、心血管疾患、自己免疫疾患などの慢性疾患の診断に使用されるため、臨床診断の分野でますます人気が高まっています。したがって、慢性疾患の有病率の増加により、免疫組織化学的ソリューションの需要が増加し、市場の成長が促進されると予想されます。

ヨーロッパ、特にフランスの国々は、新型コロナウイルス感染症の流行により大きな影響を受けています。コロナウイルス免疫組織化学抗体は、鳥類や哺乳類に感染する RNA ウイルスのコロナウイルス科のメンバーを同定するために使用できる免疫学的方法です。 SARS-CoV-2、SARS-CoV、MERS、およびネココロナウイルスなどの他の非ヒト病原体など、いくつかのコロナウイルス株によって発現される抗原に対する抗体は以下にリストされています。一般的なコロナウイルス抗体のターゲットには、ヌクレオカプシド (N) とスパイク糖タンパク質 (S) が含まれます。これらの抗体は免疫組織化学的用途を目的としています。免疫組織化学分析により、SARS-CoV-2 コロナウイルスヌクレオカプシドの差次的発現レベルの検出が示され、抗体の特異性が実証されます。 SARS/SARS-CoV-2 コロナウイルス NP モノクローナル抗体 (B46F) (カタログ番号 MA1-7404) を使用した SARS-CoV-2 コロナウイルス NP の免疫組織化学的分析では、SARS-CoV-2 に感染したヒトの肺および胎盤組織で顕著な染色が示されています。 SARS-CoV-2のない対照組織と比較した場合。英国とスウェーデンの研究者らは最近、非常に高感度の多重免疫組織化学を使用して、新型コロナウイルス感染症患者と対照の神経症状のある患者の脳周皮細胞におけるACE2発現を調べた。また、空間免疫表現型検査を使用して、新型コロナウイルス感染症患者の脳組織の炎症を評価しました。

市場の概要とダイナミクス

ヨーロッパの免疫組織化学市場は、2021年の6億3,133万米ドルから2028年までに10億2,227万米ドルに成長すると予想されています。 2021 年から 2028 年にかけて CAGR は 7.1% で成長すると推定されています。従来の診断検査は一般に、高価な機器を備え、検査を担当する訓練を受けた担当者が配置された研究室で実施されていました。過去数十年以来、診断検査は中央検査室から患者に近い検査現場へと徐々に進歩してきました。免疫組織化学に対する需要の高まりと、免疫学研究室で働くスタッフの不足により、免疫組織化学における自動化の必要性が生じています。免疫組織化学 (IHC) の自動化は、感度レベル、再現性、標準化を向上させる機会を提供するだけでなく、作業時間の短縮や試薬の節約などの利点ももたらします。分析の柔軟性は、免疫組織化学プロトコールに必要な重要な要素の 1 つです。 IHC の自動化は、免疫組織化学的手法の標準化に決定的に貢献します。さらに、16 ステップの手動手法を 5 ステップの手法に簡素化し、作業要員の数を最小限に抑えることにも役立ちます。さらに、自動化された免疫組織化学により、染色の一貫した品質と排出が保証され、さまざまな技術の標準化と最適化が向上します。さらに、自動化により信頼性が高く迅速な結果が得られるため、診断検査結果がより迅速に提供され、入院期間の短縮につながり、コストの削減につながります。したがって、免疫組織化学 (IHC) の自動化によってもたらされるさまざまなメリットは受け入れられ、今後数年間ヨーロッパ市場で一般的なトレンドの 1 つとして機能すると考えられます。

主要市場セグメント

製品の面では、抗体セグメントが 2020 年のヨーロッパの免疫組織化学市場で最大のシェアを占めました。アプリケーションの面では、診断セグメントがより大きな市場シェアを占めました。 2020 年のヨーロッパの免疫組織化学市場は、エンドユーザーベースで病院および診断研究所部門がより大きなシェアを占めました。

主要な供給源と企業リスト

ヨーロッパの免疫組織化学市場に関するこのレポートを作成するために参照されたいくつかの主要な一次および二次情報源は、企業の Web サイト、年次報告書、財務報告書、政府文書、および統計です。データベースなど。レポートに記載されている主要企業は、Abcam plc です。アジレント・テクノロジー株式会社;バイオSB;バイオラッドラボラトリーズ株式会社;セル・シグナリング・テクノロジー株式会社;ダナハー。 F. ホフマン・ラ・ロッシュ株式会社;メルクKGaA;パーキンエルマー株式会社;および THERMO FISHER SCIENTIFIC INC。

購入理由レポート

ヨーロッパの免疫組織化学市場の状況を理解し、大きな利益を保証できる可能性が最も高い市場セグメントを特定する
絶えず変化する市場を理解することで競争に先んじるヨーロッパの免疫組織化学市場の競争環境を把握する
最も売上が見込まれる市場セグメントを特定することで、ヨーロッパの免疫組織化学市場でのM&Aや提携取引を効率的に計画する
知覚的視点から知識に基づいたビジネス上の意思決定を支援します。ヨーロッパ免疫組織化学市場のさまざまなセグメントの市場パフォーマンスの包括的な分析
ヨーロッパ地域の2021年から2028年までのさまざまなセグメントごとの市場収益予測を取得します。

ヨーロッパ免疫組織化学市場セグメンテーション

>欧州免疫組織化学市場 - 製品別

装置
- スライド染色システム
- 組織マイクロアレイシステム
- 組織処理システム
- スライドスキャナ
- その他の機器
抗体
- 一次抗体
- 二次抗体
試薬
- 組織学的染色
- ブロッキング試薬および固定試薬
- >発色基質
- 固定試薬
- 安定剤
- 有機溶媒
- タンパク質分解酵素
- 希釈剤
キット

欧州免疫組織化学市場 - 用途別

診断
- がん
- 感染症
- 自己免疫疾患
- 糖尿病
- 腎臓疾患
- その他
薬物検査

ヨーロッパの免疫組織化学市場 - エンドユーザー別

病院および診断研究所
研究機関
その他

欧州免疫組織化学市場 - 国別

欧州免疫組織化学市場 - 会社概要

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Immunohistochemistry Market – By Product

1.3.2 Europe Immunohistochemistry Market – By Application

1.3.3 Europe Immunohistochemistry Market – By End User

1.3.4 Europe Immunohistochemistry Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Immunohistochemistry Market – Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

4.3 Experts Opinion

5. Europe Immunohistochemistry Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Incidences of Chronic and Infectious Diseases

5.1.2 Growing R&D Investments by Biotechnology & Biopharmaceutical Companies

5.2 Key Market Restraints

5.2.1 Issues Related to Immunohistochemistry

5.3 Key Market Opportunities

5.3.1 Opportunities in Several Countries

5.4 Future Trends

5.4.1 Use of Automation in Immunohistochemistry

5.5 Impact Analysis

6. Immunohistochemistry Market – Europe Analysis

6.1 Europe Immunohistochemistry Market Revenue Forecast and Analysis

7. Europe Immunohistochemistry Market Analysis– By Product

7.1 Overview

7.2 Europe Immunohistochemistry Market, By Product 2021 & 2028 (%)

7.3 Antibodies

7.3.1 Overview

7.3.2 Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.3 Primary Antibodies

7.3.3.1 Overview

7.3.3.2 Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.4 Secondary Antibodies

7.3.4.1 Overview

7.3.4.2 Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4 Equipment Market

7.4.1 Overview

7.4.2 Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.3 Slide Staining Systems

7.4.3.1 Overview

7.4.3.2 Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.4 Tissue Microarrays

7.4.4.1 Overview

7.4.4.2 Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.5 Tissue Processing Systems

7.4.5.1 Overview

7.4.5.2 Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.6 Slide Scanners

7.4.6.1 Overview

7.4.6.2 Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.7 Other Equipments

7.4.7.1 Overview

7.4.7.2 Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5 Reagents Market

7.5.1 Overview

7.5.2 Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.3 Histological Stains

7.5.3.1 Overview

7.5.3.2 Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.4 Blocking Sera & Reagents Market

7.5.4.1 Overview

7.5.4.2 Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.5 Chromogenic Substrates Market

7.5.5.1 Overview

7.5.5.2 Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.6 Stabilizers

7.5.6.1 Overview

7.5.6.2 Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.7 Proteolytic Enzymes

7.5.7.1 Overview

7.5.7.2 Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.8 Organic Solvents

7.5.8.1 Overview

7.5.8.2 Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.9 Fixation Reagents

7.5.9.1 Overview

7.5.9.2 Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.10 Diluents

7.5.10.1 Overview

7.5.10.2 Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.6 Kits Market

7.6.1 Overview

7.6.2 Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

8. Europe Immunohistochemistry Market Analysis – By Application

8.1 Overview

8.2 Europe Immunohistochemistry Market Share by Application 2021 & 2028 (%)

8.3 Diagnostics

8.3.1 Overview

8.3.2 Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)

8.3.3 Cancer

8.3.3.1 Overview

8.3.3.2 Cancer Market Revenue and Forecast to 2028 (US$ Mn)

8.3.4 Infectious Diseases

8.3.4.1 Overview

8.3.4.2 Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.5 Autoimmune Diseases

8.3.5.1 Overview

8.3.5.2 Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.6 Diabetes Mellitus

8.3.6.1 Overview

8.3.6.2 Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)

8.3.7 Nephrological Diseases

8.3.7.1 Overview

8.3.7.2 Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.8 Others

8.3.8.1 Overview

8.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Drug Testing

8.4.1 Overview

8.4.2 Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)

9. Europe Immunohistochemistry Market Analysis– By End User

9.1 Overview

9.2 Europe Immunohistochemistry Market, By End User 2021 & 2028 (%)

9.3 Hospital & Diagnostic Laboratories

9.3.1 Overview

9.3.2 Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.4 Research Institutes

9.4.1 Overview

9.4.2 Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.5 Others

9.5.1 Overview

9.5.2 Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10. Europe Immunohistochemistry Market – Country Analysis

10.1 Europe: Immunohistochemistry Market Revenue and Forecasts to 2028

10.1.1 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

10.1.1.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.2 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.1.2.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.1.2.2 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.1.2.3 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.1.3 UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.1.3.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.1.4 UK Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.2 Germany Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.2 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.2.2.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.2.2.2 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.2.2.3 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.2.3 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.2.3.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.2.4 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.3 France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.1 France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.2 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.3.2.1 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.3.2.2 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.3.2.3 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.3.3 France Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.3.3.1 France Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.3.4 France Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.4 Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.2 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.4.2.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.4.2.2 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.4.2.3 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.4.3 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.4.3.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.4.4 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.5 Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.5.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.5.2 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.5.2.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.5.2.2 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.5.2.3 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.5.3 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.5.3.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.5.4 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.6 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.6.1 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.6.2 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.6.2.1 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.6.2.2 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.6.2.3 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.6.3 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.6.3.1 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.6.4 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

11. Impact Of COVID-19 Pandemic on Europe Immunohistochemistry Market

11.1 Europe: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic developments

12.3.1 Overview

13. Company Profiles

13.1 Cell Signaling Technology, Inc.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 F. HOFFMANN-LA ROCHE LTD.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 MERCK KGaA

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 PerkinElmer Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 THERMO FISHER SCIENTIFIC INC.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Abcam plc

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Agilent Technologies, Inc.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 BIO-RAD LABORATORIES INC.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Danaher

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Bio SB

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

Table 2. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 3. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 4. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 5. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 6. UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 7. UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 8. UK Immunohistochemistry Market Revenue and Forecasts to 2028, by End User US$ Mn)

Table 9. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 10. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 11. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 12. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 13. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 14. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 15. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by End User US$ Mn)

Table 16. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 17. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 18. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 19. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 20. France Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 21. France Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 22. France Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 23. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 24. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 25. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 26. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 27. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 28. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 29. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 30. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 31. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 32. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 33. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 34. Spain Immunohistochemistry Market Revenue and Forecast to 2028, by Application (USD Million)

Table 35. Spain Immunohistochemistry Market Revenue and Forecast to 2028, by Diagnostics (USD Million)

Table 36. Spain Immunohistochemistry Market Revenue and Forecast to 2028, by End User (USD Million)

Table 37. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 38. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 39. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 40. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 41. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 42. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 43. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 44. Organic Developments Done By Companies

Table 45. Inorganic developments done by Companies

Table 46. Glossary of Terms

LIST OF FIGURES

Figure 1. Europe Immunohistochemistry Market Segmentation

Figure 2. Europe Immunohistochemistry Market Segmentation, By Country

Figure 3. Europe Immunohistochemistry Market Overview

Figure 4. Antibodies Segment Held the Largest Share of the Market in 2021

Figure 5. The UK to Show Significant Growth During Forecast Period

Figure 6. Europe and PEST Analysis

Figure 7. Impact Analysis of Drivers and Restraints Pertaining to Europe Immunohistochemistry Market

Figure 8. Europe Immunohistochemistry Market – Revenue Forecast and Analysis

Figure 9. Europe Immunohistochemistry Market, by Product 2021 & 2028 (%)

Figure 10. Europe Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. Europe Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. Europe Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13. Europe Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. Europe Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. Europe Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16. Europe Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. Europe Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18. Europe Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19. Europe Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. Europe Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21. Europe Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22. Europe Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23. Europe Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24. Europe Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25. Europe Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26. Europe Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27. Europe Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28. Europe Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29. Europe Immunohistochemistry Market Share by Application 2021 & 2028 (%)

Figure 30. Europe Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 31. Europe Cancer Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 32. Europe Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 33. Europe Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 34. Europe Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 35. Europe Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 36. Europe Others Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 37. Europe Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 38. Europe Immunohistochemistry Market, by End User 2021 & 2028 (%)

Figure 39. Europe Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 40. Europe Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 41. Europe Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 42. Europe: Immunohistochemistry Market Revenue Overview, by Country, 2021 (US$ MN)

Figure 43. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

Figure 44. UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 45. Germany Immunohistochemistry Products Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 46. France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 47. Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 48. Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 49. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 50. Impact of COVID-19 Pandemic in European Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe immunohistochemistry market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample